Status:
COMPLETED
Mifepristone and Misoprostol for Fetal Demise
Lead Sponsor:
University of Pittsburgh
Conditions:
Anembryonic Pregnancy
Gestation Abnormality
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
This is a pilot clinical trial to evaluate whether the medical management of early pregnancy failure with mifepristone and misoprostol is an effective and acceptable treatment. Subjects with early pre...
Eligibility Criteria
Inclusion
- healthy hemodynamically stable females with a non-viable pregnancy
- \-
Exclusion
- orthostatic hypotension, contraindication to either mifepristone or misoprostol, treatment during current pregnancy to provide surgical or medical evacuation of the uterus, evidence of ovarian hyperstimulation syndrome, known or suspected pelvic infection,known or suspected clotting defect or receiving anticoagulants, cardiovascular disease, current breastfeeding, pregnancy with and IUD in situ, current participation in another clinical trial, prior participation in this trial, suspected or confirmed endometrial AV malformation, clinical indication requiring the karyotyping of products of conception
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2005
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00177372
Start Date
January 1 2005
End Date
September 1 2005
Last Update
January 29 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Magee-Womens Hospital
Pittsburgh, Pennsylvania, United States, 15213